Measurable residual disease monitoring by NGS before allogeneic hematopoietic cell transplantation in AML.
Blood
; 132(16): 1703-1713, 2018 10 18.
Article
in En
| MEDLINE
| ID: mdl-30190321
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
/
Biomarkers, Tumor
/
Neoplasm, Residual
/
Hematopoietic Stem Cell Transplantation
/
High-Throughput Nucleotide Sequencing
/
Mutation
/
Neoplasm Recurrence, Local
Type of study:
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Aspects:
Patient_preference
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Blood
Year:
2018
Document type:
Article